Pediatric Myopia Control / 儿童青少年近视防控

Definition

Pediatric myopia control is the source’s longitudinal approach to delaying myopia onset where possible and slowing progression after it appears, using behavior, repeated measurement, optical tools, and medication without promising reversal of established true myopia.

Current Synthesis

The current evidence comes from one public ophthalmology episode. Its central distinction is between cure and control: once stable true myopia exists, clearer vision does not mean the underlying eye has returned to a non-myopic state. Prevention therefore combines lower-cost habits—breaking up near work, preserving working distance, choosing larger screens when digital learning is unavoidable, and increasing outdoor time—with follow-up that interprets refraction, axial length, corneal curvature, age, and visual behavior together.

When progression warrants more than behavior alone, the source places defocus spectacles, orthokeratology, and low-dose atropine inside individualized selection and monitoring. No single product, annual screening value, axial-length number, or prescription threshold is treated as sufficient by itself.

Key Claims

• The goal is slower onset or progression, not a promise that established true myopia can be cured.
• Near-work duration and distance, screen size, outdoor time, and broader routines are modifiable parts of prevention even when genetic susceptibility remains.
• Refraction, axial length, corneal curvature, age, and visual behavior need longitudinal, combined interpretation.
• Defocus spectacles, orthokeratology, and low-dose atropine are control options whose suitability and effects vary by child.
• High-myopia prevention matters because axial elongation can increase retinal and macular risk even when optical correction restores clear vision.

Evidence

• Cure-versus-control boundary: VOL.163 says true myopia generally does not reverse and frames prevention as slowing its development.
• Behavioral foundation: VOL.163 recommends breaks from near work, reasonable viewing distance, larger screens when unavoidable, and at least two outdoor hours daily.
• Longitudinal assessment: VOL.163 asks clinicians to read vision, refraction, axial length, corneal curvature, age, and use pattern together.
• Intervention choice: VOL.163 compares defocus spectacles, orthokeratology, and low-dose atropine while emphasizing variable response and staged reassessment.
• Risk rationale: VOL.163 connects longer axial length with retinal thinning, tears, detachment, and macular complications.

Counterevidence & Qualifications

The page summarizes one podcast source, not a pediatric ophthalmology guideline. Exact outdoor-time targets, age bands, expected control percentages, prescription limits, drug concentrations, follow-up intervals, and combinations can depend on examination findings, product design, local approval, adherence, adverse effects, and clinician judgment. Screen or posture advice should not be read as proof that one habit alone caused an individual child’s myopia.

What Changed

• Created a longitudinal myopia-control concept that separates slowing progression from curing established true myopia.
• Joined basic behavior, repeated measurement, optical control, medication, and high-myopia risk in one framework.

Related Concepts

• Orthokeratology Myopia Control / 角膜塑形镜近视控制 - optical control option using temporary corneal reshaping and peripheral defocus.
• Cycloplegic Refraction / 睫状肌麻痹验光 - assessment method that reduces accommodation before a stable prescription is inferred.
• Myopia Surgery Risk Boundary / 近视手术风险边界 - parallel distinction between clear vision and elimination of underlying myopia-related risk.
• Preventive Health Screening - broader framework for repeated measurements and early intervention.
• Medical Risk Management - safety frame for matching benefit, burden, adverse effects, and monitoring.